NEW YORK, April 7, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Veradigm Inc. MDRXLive Person, Inc. LPSNBank of the First Republic FRCand Zynex, Inc. CYXI. Our investigations address whether these companies have violated federal securities laws and/or engaged in other illegal business practices. For more information on each case, see the link provided.

Veradigm Inc. MDRX

On February 28, 2023, Veradigm announced that it had “identified certain internal control errors related to revenue recognition that occurred in the prior six quarters, which have resulted in a misstatement of reported revenue for those periods.” As a result, the company reported that it “expects an overall decrease in income from continuing operations of approximately $20 million from what it has otherwise reported since Q3 2021 and is expected to report in Q4 2022.” . The company added that it “continues to assess the materiality of the misstatement to determine whether the full amount of this adjustment will flow through in Q4 2022 or whether prior periods will also require an adjustment.” As a result, Veradigm revised down its 2023 guidance and said it would not file its 2022 annual report on time.

As a result of this news, Veradigm’s stock price fell $2.12 per share, or 12.76%, to close at $14.49 per share on March 1, 2023.

For more information on the Veradigm investigation, visit: https://bespc.com/cases/MDRX

LivePerson, Inc. LPSN

On March 15, 2023, LivePerson issued a press release announcing its fourth quarter 2022 financial results. The company announced that WildHealth, the company’s subsidiary, has received notification that Medicare is suspending reimbursement for services provided under the Medicare demonstration program pending further review. As a result, LivePerson decided to set aside a reserve for revenue related to…